post partum hemorrhage - Nursing Case Study

Pathophysiology

• Primary mechanism: Uterine atony - The most common cause of postpartum hemorrhage, where the uterus fails to contract effectively after delivery, leading to excessive bleeding. Without adequate contraction, the uterine blood vessels are not compressed, resulting in continued blood loss.

• Secondary mechanism: Retained placental tissue - Remaining fragments of the placenta in the uterus can prevent proper uterine contraction and lead to persistent bleeding. This retained tissue may also prompt an inflammatory response, exacerbating hemorrhagic risk.

• Key complication: Hypovolemic shock - If not promptly managed, the excessive blood loss can lead to decreased blood volume, causing hypovolemic shock. This condition can severely impair organ function and is potentially life-threatening, necessitating immediate intervention.

Patient Profile

Demographics:

32-year-old female, teacher

History:

• Key past medical history: Gestational hypertension, previous cesarean section

• Current medications: Labetalol, prenatal vitamins

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Excessive vaginal bleeding after childbirth

• Key symptoms: Dizziness, fatigue, shortness of breath

• Vital signs: Blood pressure 90/60 mmHg, heart rate 120 bpm, respiratory rate 24 breaths per minute, temperature 37.2°C

Section 1

Change in Patient Status:

As the medical team continues to manage the patient's postpartum hemorrhage, there is a noticeable change in her status. Despite initial interventions, including uterine massage and administration of oxytocin to stimulate uterine contractions, the bleeding persists. The patient's blood pressure has dropped further to 85/55 mmHg, and her heart rate remains elevated at 130 bpm, indicating worsening signs of hypovolemia. Her skin is cool and clammy, and she is becoming increasingly lethargic and disoriented, suggesting a progression towards hypovolemic shock.

The clinical team quickly reassesses the situation. Given the lack of response to initial treatments and the patient's deteriorating condition, they suspect that retained placental tissue may be contributing significantly to the ongoing hemorrhage. An ultrasound is urgently ordered to evaluate the uterine cavity for any retained products of conception. Meanwhile, the team prepares for potential surgical intervention, such as dilation and curettage, to remove any remaining placental tissue, should the ultrasound confirm this suspicion. Additionally, blood products are cross-matched and prepared for transfusion to address her critical blood loss and support hemodynamic stability.

The worsening of the patient's condition prompts the team to consider broader aspects of her care, including close monitoring in a high-dependency unit and consultation with the multidisciplinary team, including obstetrics, anesthesiology, and critical care specialists. These steps are crucial to preemptively manage any further complications and stabilize the patient as quickly as possible.

Section 2

New Diagnostic Results:

The ultrasound results are promptly reviewed, revealing a significant amount of retained placental tissue within the uterine cavity. This finding confirms the initial suspicion and provides a clear explanation for the ongoing hemorrhage despite prior interventions. The presence of retained tissue is contributing to uterine atony and preventing effective contraction, exacerbating blood loss. In conjunction with the ultrasound results, laboratory tests indicate a hemoglobin level of 7.5 g/dL, confirming significant anemia secondary to the hemorrhage. Her hematocrit has dropped to 22%, and her platelets are slightly reduced at 130,000/mm³, raising concerns about her coagulation status.

Recognizing the urgency of the situation, the clinical team decides to proceed with an emergency dilation and curettage (D&C) to evacuate the retained placental tissue. In preparation for the procedure, the anesthesiology team is consulted to ensure the patient's hemodynamic stability during surgery. Blood transfusions are initiated, with two units of packed red blood cells ordered to address her anemia and improve oxygen delivery. The multidisciplinary team coordinates closely, with critical care specialists on standby to manage potential complications during and after the procedure. Continuous monitoring of her vital signs, including blood pressure, heart rate, and oxygen saturation, is maintained to detect any adverse changes promptly.

The decision to perform a D&C and the initiation of blood transfusion mark a pivotal point in the patient's care, with the aim to rapidly control the hemorrhage and stabilize her condition. The clinical team remains vigilant, anticipating the potential need for further interventions depending on her response and any additional complications that may arise. This proactive approach underscores the importance of timely diagnostics and coordinated care in managing complex postpartum hemorrhage cases.

Section 3

Response to Interventions:

Following the emergency dilation and curettage (D&C), the patient is transferred to the recovery area for close observation. Initial assessments post-procedure show a modest improvement in her condition. Her vital signs indicate a stabilized blood pressure at 110/70 mmHg and a heart rate of 98 beats per minute, down from the tachycardic state she was in prior to the intervention. Oxygen saturation is maintained at 95% on supplemental oxygen via nasal cannula. The transfusion of two units of packed red blood cells has effectively raised her hemoglobin to 9.0 g/dL, reflecting an improvement in her anemia, although her hematocrit remains low at 25%.

The nursing team continues to monitor her for signs of ongoing bleeding or other complications. However, despite the initial stabilization, there are concerns about her persistent low platelet count, which remains at 125,000/mm³. This raises the suspicion of an underlying coagulopathy, possibly disseminated intravascular coagulation (DIC), particularly given the prior massive hemorrhage and retained tissue. The clinical team orders a coagulation panel, including prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen levels, to further investigate her coagulation status.

As the patient begins to regain consciousness, she reports mild abdominal pain and is visibly fatigued, though alert. Her urine output, monitored via a Foley catheter, is noted to be decreasing, which prompts further evaluation for potential renal impairment. The critical care team remains on standby, prepared to address any emergent issues. This ongoing vigilance is crucial, as the patient’s recovery trajectory depends on the prompt identification and management of any additional complications that could arise from the cascade of events initiated by the postpartum hemorrhage. The next steps will focus on stabilizing her coagulation status and ensuring renal function is not compromised, as these are pivotal to her overall recovery.

Section 4

New Diagnostic Results:

The results of the coagulation panel return, revealing significant abnormalities that confirm the presence of coagulopathy. The patient's prothrombin time (PT) is prolonged at 18 seconds, and the activated partial thromboplastin time (aPTT) is also extended at 48 seconds. Additionally, her fibrinogen level is notably low at 150 mg/dL, supporting the suspicion of disseminated intravascular coagulation (DIC). These findings necessitate immediate intervention to prevent further complications. The medical team initiates a protocol for DIC management, which includes the administration of fresh frozen plasma (FFP) to replenish clotting factors and cryoprecipitate to address the low fibrinogen level.

While managing the coagulopathy, the team also revisits the patient's decreasing urine output, which has now fallen to 20 mL per hour over the last two hours. This drop raises concerns of acute kidney injury (AKI), likely secondary to hypoperfusion during the initial hemorrhage and ongoing hemodynamic instability. A renal ultrasound is ordered to assess for any structural abnormalities, while nephrology is consulted for further evaluation and management. Intravenous fluids are cautiously adjusted to optimize renal perfusion without exacerbating any potential fluid overload, given her current state.

The clinical reasoning now focuses on balancing the correction of the coagulation disturbances while simultaneously addressing the renal impairment. The team is vigilant in monitoring for signs of fluid overload, changes in mental status, and further bleeding, all of which could complicate the patient's recovery. The coordinated efforts of the multidisciplinary team are crucial in navigating this complex clinical situation, as they work towards stabilizing the patient's condition and preventing further deterioration. The next phase will involve close monitoring of her response to these interventions, with adjustments made as necessary based on her evolving clinical status.

Section 5

The patient's condition continues to evolve as new complications arise. Despite the administration of fresh frozen plasma and cryoprecipitate, her coagulation profile remains abnormal, with a slight improvement in prothrombin time to 16 seconds but persistent elongation of the activated partial thromboplastin time at 45 seconds. Her fibrinogen level has increased marginally to 180 mg/dL, indicating a partial response to therapy but highlighting the ongoing challenge in fully correcting the coagulopathy. The patient exhibits mild oozing at the IV sites and has developed petechiae on her lower extremities, further indicating a delicate hemostatic balance.

Meanwhile, her renal function is closely monitored. The renal ultrasound reveals no structural abnormalities, but her serum creatinine has risen to 1.8 mg/dL from a baseline of 0.9 mg/dL, confirming the development of acute kidney injury. The nephrology team recommends the continuation of careful fluid management and considers the potential need for renal replacement therapy should her renal function continue to deteriorate. Despite these challenges, her vital signs remain stable, with a heart rate of 92 beats per minute, blood pressure of 110/70 mmHg, and oxygen saturation of 96% on room air, indicating adequate hemodynamic support at this time.

The multidisciplinary team remains vigilant, conducting frequent assessments to detect any subtle changes. They focus on ensuring adequate tissue perfusion while preventing fluid overload and further bleeding. As the patient responds variably to interventions, the team prepares for potential escalation of care, including the possibility of initiating dialysis or additional transfusion support. This scenario underscores the importance of dynamic clinical reasoning and adaptation to the patient’s changing status, as they work towards stabilizing her condition and guiding her safely through this critical phase.